What makes scale-up of industrial biotechnology so difficult?
By Mark Warner, PE, Founder, Warner Advisors LLC, Special to The Digest Two questions have dominated the responses received after my Lessons Learned series on commercializing industrial biotechnology (here) and the deep-dive into the industrial biotechnology commercialization process (here), the questions are what makes scale-up of industrial biotechnology so difficult and of course how can risk […]














